These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 23647880)

  • 1. Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: a population-based cohort study.
    Pinholt M; Ostergaard C; Arpi M; Bruun NE; Schønheyder HC; Gradel KO; Søgaard M; Knudsen JD;
    Clin Microbiol Infect; 2014 Feb; 20(2):145-51. PubMed ID: 23647880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review.
    McBride SJ; Upton A; Roberts SA
    Eur J Clin Microbiol Infect Dis; 2010 Jan; 29(1):107-14. PubMed ID: 19916034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis.
    Lu CL; Chuang YC; Chang HC; Chen YC; Wang JT; Chang SC
    J Antimicrob Chemother; 2012 Sep; 67(9):2243-9. PubMed ID: 22618861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study.
    Scharloo F; Cogliati Dezza F; López-Hernández I; Martínez Pérez-Crespo PM; Goikoetxea Aguirre AJ; Pérez-Rodríguez MT; Fernandez-Suarez J; León Jiménez E; Morán Rodríguez MÁ; Fernández-Natal I; Reguera Iglesias JM; Natera Kindelán C; Fariñas Álvares MC; Boix-Palop L; Lopez-Cortes LE; Rodríguez-Baño J;
    Eur J Clin Microbiol Infect Dis; 2024 Oct; 43(10):2011-2022. PubMed ID: 39112668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single center experience of a vancomycin resistant enterococcal endocarditis cohort.
    Forrest GN; Arnold RS; Gammie JS; Gilliam BL
    J Infect; 2011 Dec; 63(6):420-8. PubMed ID: 21920382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Australian Enterococcal Sepsis Outcome Programme annual report, 2013.
    Coombs GW; Pearson JC; Daly DA; Le TT; Robinson JO; Gottlieb T; Howden BP; Johnson PD; Bennett CM; Stinear TP; Turnidge JD;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E320-6. PubMed ID: 25631594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enterococcal bacteraemia: predictive and prognostic risk factors for ampicillin resistance.
    Matsumura T; Nagao M; Nakano S; Yamamoto M; Matsumura Y; Ichiyama S
    Epidemiol Infect; 2018 Dec; 146(16):2028-2035. PubMed ID: 30165917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children.
    Aamodt H; Mohn SC; Maselle S; Manji KP; Willems R; Jureen R; Langeland N; Blomberg B
    BMC Infect Dis; 2015 Feb; 15():107. PubMed ID: 25884316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of a cohort of patients with Enterococcus spp. Bacteraemia. Risk factors associated to high-level resistance to aminoglycosides].
    García-Vázquez E; Albendín H; Hernández-Torres A; Canteras M; Yagüe G; Ruiz J; Gómez J
    Rev Esp Quimioter; 2013 Sep; 26(3):203-13. PubMed ID: 24080886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.
    Cheah AL; Spelman T; Liew D; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
    Clin Microbiol Infect; 2013 Apr; 19(4):E181-9. PubMed ID: 23398607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enterococcal bacteremia at Nîmes university hospital].
    Lavigne JP; Marchandin H; Czarnecki E; Kaye C; Sotto A
    Pathol Biol (Paris); 2005; 53(8-9):539-45. PubMed ID: 16084034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study.
    Billington EO; Phang SH; Gregson DB; Pitout JD; Ross T; Church DL; Laupland KB; Parkins MD
    Int J Infect Dis; 2014 Sep; 26():76-82. PubMed ID: 24813873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
    Mohr JF; Friedrich LV; Yankelev S; Lamp KC
    Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia in cancer patients.
    Conde-Estévez D; Grau S; Albanell J; Terradas R; Salvadó M; Knobel H
    Eur J Clin Microbiol Infect Dis; 2011 Jan; 30(1):103-8. PubMed ID: 20711795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of temporal clusters and risk factors of bacteremia by nosocomial vancomycin-resistant enterococci.
    da Silva NS; Muniz VD; Estofolete CF; Furtado GH; Rubio FG
    Am J Infect Control; 2014 Apr; 42(4):389-92. PubMed ID: 24679566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of risk factors and outcome in patients with Enterococcus faecalis vs Enterococcus faecium bacteraemia.
    Suppola JP; Kuikka A; Vaara M; Valtonen VV
    Scand J Infect Dis; 1998; 30(2):153-7. PubMed ID: 9730302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteraemia caused by non-faecalis and non-faecium Enterococcus species-a retrospective study of incidence, focus of infection, and prognosis.
    Lohikoski R; Oldberg K; Rasmussen M
    Eur J Clin Microbiol Infect Dis; 2024 Jan; 43(1):45-53. PubMed ID: 37919410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective observational study on enterococcal bacteraemia and endocarditis at a regional hospital in New South Wales, Australia.
    Lwin N; Bannan A
    Infect Dis Health; 2020 Nov; 25(4):245-252. PubMed ID: 32561340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
    Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I
    Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.